Meeting
2021 ASCO Annual Meeting
A mixed methods study exploring the role of perceived side effects on treatment decision-making in older adults with acute myeloid leukemia (AML).
Authors
Dawn Maze
Princess Margaret Cancer Centre, Toronto, ON, Canada
Dawn Maze , Roland B. Walter , Diana M. Merino , Timothy J. Bell , Louise O'Hara , Francois Peloquin , Lucy Morgan , Loriana Hernandez , Jasmine Healy , Charlotte Panter , Verna L. Welch , Adam Gater , Karim Amer , Ryan Hohman , Julia Stein , Andrew Brown , Nigel H. Russell , Thomas William LeBlanc
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Track
Hematologic Malignancies
Sub Track
Acute Leukemia
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 7016)
DOI
10.1200/JCO.2021.39.15_suppl.7016
Abstract #
7016
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
A fork in the road: A mixed methods study exploring why older adults with acute myeloid leukemia choose different treatment paths.
First Author: Thomas William LeBlanc
Poster
2015 Gastrointestinal Cancers Symposium
Safety and efficacy of modified dose-attenuated FOLFIRINOX chemotherapy in patients over 65 years with advanced pancreatic adenocarcinoma.
First Author: Matheus Bongers Alessandretti
Poster
2015 Gastrointestinal Cancers Symposium
Impact of CGA in therapeutic decisions: ELDERLY trial.
First Author: Javier Gallego Plazas
Poster
2024 ASCO Genitourinary Cancers Symposium
Real-world efficacy and toxicity of ipilimumab and nivolumab as first line treatment of metastatic renal cell carcinoma (mRCC) in a subpopulation of elderly and poor performance status patients.
First Author: Ana-Alicia Beltran-Bless